Thyroid DisordersApril 12, 20265 min read

Q-Bank Breakdown: Thyroid cancer (papillary, follicular, medullary, anaplastic) — Why Every Answer Choice Matters

Clinical vignette on Thyroid cancer (papillary, follicular, medullary, anaplastic). Explain correct answer, then systematically address each distractor. Tag: Endocrine > Thyroid Disorders.

A good thyroid cancer question isn’t really about “spotting the tumor”—it’s about recognizing patterns and eliminating look-alikes fast. The USMLE loves thyroid malignancies because each one has a signature combo of risk factors, spread pattern, histology, and tumor markers. Let’s walk through a classic vignette and then break down every answer choice like you would in a Q-bank review.


Clinical Vignette (Q-Bank Style)

A 32-year-old woman presents with a painless thyroid nodule discovered incidentally. She had radiation therapy to the neck as a child for Hodgkin lymphoma. Exam shows a firm 1.5 cm thyroid nodule. Ultrasound reveals a solid hypoechoic nodule with microcalcifications. Fine-needle aspiration shows cells with optically clear nuclei and nuclear grooves.

Which of the following is the most likely diagnosis?

A. Papillary thyroid carcinoma
B. Follicular thyroid carcinoma
C. Medullary thyroid carcinoma
D. Anaplastic thyroid carcinoma


Correct Answer: A. Papillary thyroid carcinoma

Why this is papillary (the “buzzword stack”)

This vignette practically hands you papillary thyroid carcinoma (PTC):

  • History of childhood neck radiation → major risk factor for PTC
  • Ultrasound: microcalcifications → suggests psammoma bodies
  • FNA: “Orphan Annie eye” nuclei + nuclear grooves → classic for PTC

High-yield PTC snapshot

  • Most common thyroid cancer overall
  • Spreads via lymphatics → cervical lymph node metastases are common
  • Histology:
    • Papillae
    • Psammoma bodies (concentric calcifications)
    • Orphan Annie eye nuclei (cleared-out nuclei)
  • Associations:
    • Radiation exposure
    • RET/PTC rearrangements, BRAF mutations (common in sporadic PTC)
💡

USMLE pearl: A thyroid cancer with lymph node spread + “Orphan Annie eye” nuclei is papillary until proven otherwise.


Now Destroy the Distractors (Why Every Answer Choice Matters)

B. Follicular thyroid carcinoma — why it’s tempting, why it’s wrong here

Follicular thyroid carcinoma (FTC) can present as a solitary thyroid nodule, and it’s the second most common well-differentiated thyroid malignancy. But the distinguishing features don’t match.

What would point to follicular instead?

  • Hematogenous spread (not lymphatic)
    • Classically to bone and lungs
  • Histology: follicles that resemble normal thyroid, but with invasion
    • The key diagnosis is capsular and/or vascular invasion
    • FNA cannot distinguish follicular adenoma vs carcinoma because invasion can’t be assessed on cytology alone

Classic associations

  • Iodine deficiency (more relevant globally; still tested)
  • Mutations: RAS, PAX8-PPARγ\gamma fusion

Why it’s wrong in this vignette

  • The vignette gives papillary-specific cytology (Orphan Annie eyes, nuclear grooves)
  • The ultrasound’s microcalcifications lean papillary (psammoma bodies)
  • Radiation exposure is more classically tied to papillary
💡

USMLE pearl: If the stem emphasizes capsular/vascular invasion or distant mets to bone, think follicular.


C. Medullary thyroid carcinoma — what you must recognize immediately

Medullary thyroid carcinoma (MTC) is neuroendocrine—derived from parafollicular C cells, not follicular cells. This changes everything: marker, histology, genetics, symptoms.

What would point to medullary instead?

  • Elevated calcitonin (major clue)
  • Amyloid stroma from calcitonin deposition
    • Congo red positive with apple-green birefringence
  • Can cause diarrhea/flushing (bioactive peptides)
  • Strong association with MEN 2 syndromes:
    • MEN 2A: MTC + pheochromocytoma + hyperparathyroidism
    • MEN 2B: MTC + pheochromocytoma + mucosal neuromas + marfanoid habitus
  • RET mutation (activating) is the classic genetic driver

Why it’s wrong in this vignette

  • No mention of calcitonin, amyloid, diarrhea/flushing, or MEN features
  • Cytology given is papillary, not neuroendocrine
💡

USMLE pearl: Before thyroid surgery in suspected MEN2/MTC, you must rule out pheochromocytoma—or the patient can crash intraoperatively from catecholamine surge.


D. Anaplastic thyroid carcinoma — the “older patient + rapidly fatal” tumor

Anaplastic thyroid carcinoma is aggressive, undifferentiated, and shows up as a rapidly enlarging neck mass causing compressive symptoms.

What would point to anaplastic instead?

  • Elderly patient (typically 60–80)
  • Rapidly enlarging, painful mass
  • Compressive symptoms:
    • Dysphagia, dyspnea, hoarseness/stridor
  • Often arises from dedifferentiation of a prior well-differentiated thyroid cancer
  • Histology: pleomorphic giant cells/spindle cells, very high mitotic activity
  • Very poor prognosis (often fatal within months)

Why it’s wrong in this vignette

  • Patient is young (32)
  • Nodule is small and incidental, not rapidly enlarging
  • Cytology described is classic papillary—not undifferentiated pleomorphism
💡

USMLE pearl: “Rock-hard, fast-growing thyroid mass with airway symptoms in an older patient” = anaplastic until proven otherwise.


One Table to Lock It In (Step 1 + Step 2 High Yield)

CancerCell of originSpreadKey cluesHistologyMarker/Mutation
PapillaryFollicular cellsLymphaticRadiation exposure, microcalcificationsOrphan Annie nuclei, nuclear grooves, psammoma bodiesBRAF, RET/PTC
FollicularFollicular cellsHematogenous“Cold” nodule; distant mets (bone/lung)Capsular/vascular invasion (can’t be seen on FNA)RAS, PAX8-PPARγ\gamma
MedullaryC cellsEarly mets (nodes, then distant)MEN2, diarrhea/flushingAmyloid stromaCalcitonin, RET
AnaplasticUndifferentiated (often from prior differentiated ca)Invasive local + distantOlder, rapidly enlarging neck mass, compressive sxPleomorphic giant/spindle cellsp53 (often), very aggressive

Rapid-Fire Q-Bank “Elimination Moves”

When you’re stuck between options, ask:

1) How does it spread?

  • Lymph nodes → papillary
  • Blood (bone/lung) → follicular

2) What’s the biomarker?

  • Calcitonin → medullary
  • Thyroglobulin can be used as a tumor marker for recurrence in differentiated cancers (papillary/follicular), but it’s not the classic diagnostic giveaway in stems

3) What’s the patient’s age and tempo?

  • Young/middle-aged + slow-growing → papillary/follicular
  • Older + explosive growth + airway compromise → anaplastic

4) What does FNA actually tell you?

  • Papillary: yes, FNA often diagnostic
  • Follicular: no, because you need capsular/vascular invasion on surgical pathology
  • Medullary: FNA can suggest, but calcitonin/amyloid and MEN workup are key
  • Anaplastic: FNA may show undifferentiated malignant cells

Takeaway (What You Should Remember on Test Day)

  • Papillary: most common; radiation; Orphan Annie eye nuclei, psammoma bodies; lymphatic spread
  • Follicular: hematogenous spread; diagnosis needs invasion (not just FNA)
  • Medullary: C cells, calcitonin, amyloid, MEN2/RET
  • Anaplastic: older, rapidly enlarging, compressive symptoms, worst prognosis